Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Diseases

  Free Subscription


18.03.2024

1 Am J Gastroenterol
2 Biochem Biophys Res Commun
2 BMC Cancer
1 Br J Surg
4 Cancer Res
8 Clin Res Hepatol Gastroenterol
1 Dig Dis Sci
1 Endoscopy
2 Eur Radiol
2 Gut
10 Hepatology
1 Indian J Gastroenterol
1 Int J Cancer
1 J Gastroenterol
4 J Hepatol
3 PLoS One
1 Radiology
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. SAMALA N, Xin Y, Wilson LA, Yates K, et al
    Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for clinical risk factors and PNPLA3 genotype.
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002756.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  2. PENG J, Liang G, Li Y, Mao S, et al
    Identification of a novel FOXO3 agonist that protects against alcohol induced liver injury.
    Biochem Biophys Res Commun. 2024;704:149690.
    PubMed         Abstract available

  3. SHANG S, Wan Q, Chen F, Hu J, et al
    Co-targeting ASK1 and THRbeta synergistically improves steatohepatitis and fibrosis in a MASH animal model.
    Biochem Biophys Res Commun. 2024;705:149739.
    PubMed         Abstract available


    BMC Cancer

  4. PAN T, Li J, Zhang O, Zhu Y, et al
    Knockdown of ribosome RNA processing protein 15 suppresses migration of hepatocellular carcinoma through inhibiting PATZ1-associated LAMC2/FAK pathway.
    BMC Cancer. 2024;24:334.
    PubMed         Abstract available

  5. LEE JH, Hong YM
    The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma.
    BMC Cancer. 2024;24:327.
    PubMed         Abstract available


    Br J Surg

  6. MAJLESARA A, Golriz M, Ramouz A, Khajeh E, et al
    Portal vein arterialization as a salvage method in advanced hepatopancreatobiliary surgery.
    Br J Surg. 2024;111:znae053.
    PubMed        


    Cancer Res

  7. HUANG J, Tsang WY, Fang XN, Zhang Y, et al
    FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.
    Cancer Res. 2024;84:855-871.
    PubMed         Abstract available

  8. WENG J, Wang Z, Hu Z, Xu W, et al
    Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy.
    Cancer Res. 2024 Mar 14. doi: 10.1158/0008-5472.CAN-23-3106.
    PubMed         Abstract available

  9. LIAO H, Chen X, Wang H, Lin Y, et al
    Whole-genome DNA methylation profiling of intrahepatic cholangiocarcinoma reveals prognostic subtypes with distinct biological drivers.
    Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-23-3298.
    PubMed         Abstract available

  10. WAN S, He QY, Yang Y, Liu F, et al
    SPARC stabilizes ApoE to induce cholesterol-dependent invasion and sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-23-2889.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  11. AN Y, Xia Y, Wang Z, Jin GZ, et al
    Clinical significance of ribosome production factor 2 homolog in hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2024;48:102289.
    PubMed         Abstract available

  12. HAYAT HMS, Naeem H
    Aspirin for non alcoholic fatty liver disease: Promising but inconclusive-A letter to the editor.
    Clin Res Hepatol Gastroenterol. 2024;48:102286.
    PubMed        

  13. HOOSHMAND GHARABAGH L, Shargh A, Mohammad Hosseini Azar MR, Esmaeili A, et al
    Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102279.
    PubMed         Abstract available

  14. THABUT D, Roux J, Simon-Sultanik P, Tamberou C, et al
    Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: a study of the French Hospital-Discharge Database.
    Clin Res Hepatol Gastroenterol. 2023 Dec 26:102274.
    PubMed         Abstract available

  15. CHEN F, Chen C, Zhang Y, Jiang L, et al
    Bilateral optic atrophy in Wilson disease: A case report and literature review.
    Clin Res Hepatol Gastroenterol. 2024;48:102299.
    PubMed         Abstract available

  16. RAN D, Xin C, Ma Y, Lu Y, et al
    Increased risk of colorectal adenomas with metabolic-associated fatty liver disease components.
    Clin Res Hepatol Gastroenterol. 2024;48:102302.
    PubMed         Abstract available

  17. LI B, Ren ZW, Zhang C, Yu XX, et al
    Computed tomography-guided percutaneous cryoablation and microwave ablation in the treatment of perivascular hepatocellular carcinoma: A comparative study with propensity score matching.
    Clin Res Hepatol Gastroenterol. 2024;48:102298.
    PubMed         Abstract available

  18. NDHLOVU E, Zhang BX, Chen XP, Zhu P, et al
    Thermal ablation for hepatic tumors in high-risk locations.
    Clin Res Hepatol Gastroenterol. 2024;48:102300.
    PubMed         Abstract available


    Dig Dis Sci

  19. KAHN-BOESEL O, Mitchell H, Li L, Zhu E, et al
    Hospital-Level Care at Home for Patients with Cirrhosis.
    Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08361.
    PubMed         Abstract available


    Endoscopy

  20. HASSAN KM, Dawod E, Hassan M, Salgado SM, et al
    Endoscopic treatment of a hepatic abscess arising from a biliary stricture due to intraductal papillary neoplasm of the bile duct.
    Endoscopy. 2024;56.
    PubMed        


    Eur Radiol

  21. BYENFELDT M, Kihlberg J, Nasr P, Gronlund C, et al
    Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound.
    Eur Radiol. 2024 Mar 8. doi: 10.1007/s00330-024-10655.
    PubMed         Abstract available

  22. BOUATTOUR M, Vilgrain V, Sepulveda A
    ESR Bridges: imaging and treatment of hepatocellular carcinoma-a multidisciplinary view.
    Eur Radiol. 2024 Mar 15. doi: 10.1007/s00330-023-10579.
    PubMed        


    Gut

  23. TARGHER G, Byrne CD, Tilg H
    MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.
    Gut. 2024;73:691-702.
    PubMed         Abstract available

  24. HILDT E, Hu J
    New facet of CARs: HBV-specific CARs as inhibitors of virus morphogenesis and release.
    Gut. 2024;73:566-567.
    PubMed        


    Hepatology

  25. PARK JG, Roh PR, Kang MW, Cho SW, et al
    Intrahepatic immunoglobulin a complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of hepatocellular carcinoma.
    Hepatology. 2024 Feb 15. doi: 10.1097/HEP.0000000000000772.
    PubMed         Abstract available

  26. STERLING RK, Asrani SK, Levine D, Duarte-Rojo A, et al
    AASLD Practice Guideline on non-invasive liver disease assessments of portal hypertension.
    Hepatology. 2024 Mar 15. doi: 10.1097/HEP.0000000000000844.
    PubMed        

  27. STERLING RK, Patel K, Duarte-Rojo A, Asrani SK, et al
    AASLD Practice Guideline on blood-based non-invasive liver disease assessments of hepatic fibrosis and steatosis.
    Hepatology. 2024 Mar 15. doi: 10.1097/HEP.0000000000000845.
    PubMed        

  28. STERLING RK, Duarte-Rojo A, Patel K, Asrani SK, et al
    AASLD Practice Guideline on imaging-based non-invasive liver disease assessments of hepatic fibrosis and steatosis.
    Hepatology. 2024 Mar 15. doi: 10.1097/HEP.0000000000000843.
    PubMed        

  29. ROCKEY DC, Alsawas M, Rojo-Duarte A, Patel K, et al
    Non-invasive liver disease assessment to identify portal hypertension: A systematic review supporting the AASLD Practice Guideline.
    Hepatology. 2024 Mar 15. doi: 10.1097/HEP.0000000000000841.
    PubMed         Abstract available

  30. DIETZ-FRICKE C, Degasperi E, Jachs M, Maasoumy B, et al
    Safety and efficacy of off-label bulevirtide monotherapy in HDV patients with decompensated Child-B cirrhosis - a real world case series.
    Hepatology. 2024 Mar 13. doi: 10.1097/HEP.0000000000000847.
    PubMed         Abstract available

  31. MARCHETTI A, Pelusi S, Marella A, Malvestiti F, et al
    Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.
    Hepatology. 2024 Mar 11. doi: 10.1097/HEP.0000000000000839.
    PubMed         Abstract available

  32. BU W, Sun X, Xue X, Geng S, et al
    Early onset of pathological polyploidization and cellular senescence in hepatocytes lacking RAD51 creates a pro-fibrotic and pro-tumorigenic inflammatory microenvironment.
    Hepatology. 2024 Mar 11. doi: 10.1097/HEP.0000000000000821.
    PubMed         Abstract available

  33. MUNOZ AE, Rodger EG
    Letter to the Editor: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
    Hepatology. 2024 Mar 11. doi: 10.1097/HEP.0000000000000846.
    PubMed        

  34. SHARPTON S, Loomba R
    Response to Letter to the Editor: emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
    Hepatology. 2024 Mar 11. doi: 10.1097/HEP.0000000000000848.
    PubMed        


    Indian J Gastroenterol

  35. RAMEGOWDA R, Gupta P
    Abbreviated magnetic resonance imaging in hepatocellular carcinoma surveillance: A review.
    Indian J Gastroenterol. 2024 Mar 9. doi: 10.1007/s12664-023-01511.
    PubMed         Abstract available


    Int J Cancer

  36. GERBER TS, Ridder DA, Goeppert B, Brobeil A, et al
    N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
    Int J Cancer. 2024;154:1857-1868.
    PubMed         Abstract available


    J Gastroenterol

  37. XIN HY, Zou JX, Sun RQ, Hu ZQ, et al
    Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.
    J Gastroenterol. 2024 Mar 10. doi: 10.1007/s00535-024-02090.
    PubMed         Abstract available


    J Hepatol

  38. TOMLINSON JL, Li B, Yang J, Loeuillard E, et al
    Syngeneic Murine Models with Distinct Immune Microenvironments Represent Subsets of Human Intrahepatic Cholangiocarcinoma.
    J Hepatol. 2024 Mar 6:S0168-8278(24)00127-2. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  39. CHOI SH, Lee BM, Kim J, Kim DY, et al
    Efficacy of Stereotactic Ablative Radiotherapy in Patients with Oligometastatic Hepatocellular Carcinoma: A Phase II Study.
    J Hepatol. 2024 Mar 9:S0168-8278(24)00154-5. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  40. JACHS M, Sandmann L, Hartl L, Tergast T, et al
    Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
    J Hepatol. 2024 Mar 11:S0168-8278(24)00156-9. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  41. MA AT, Sole C, Juanola A, Escude L, et al
    Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.
    J Hepatol. 2024 Mar 11:S0168-8278(24)00157-0. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available


    PLoS One

  42. LI H, Wang C
    MIS-Net: A deep learning-based multi-class segmentation model for CT images.
    PLoS One. 2024;19:e0299970.
    PubMed         Abstract available

  43. YAMASHITA T, Suzuki N, Motoyoshi K, Zhu W, et al
    Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan.
    PLoS One. 2024;19:e0298420.
    PubMed         Abstract available

  44. KANEKO S, Asahina Y, Murakawa M, Azuma S, et al
    Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.
    PLoS One. 2024;19:e0297882.
    PubMed         Abstract available


    Radiology

  45. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
    Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
    Radiology. 2024;310:e231220.
    PubMed         Abstract available


    Transplant Proc

  46. LIM WX, Sim KS, Chen CL, Ou HY, et al
    Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: The Effectiveness of Different Particle Sizes in Downstaging and Bridging in Living Donor Liver Transplantation.
    Transplant Proc. 2024 Mar 11:S0041-1345(24)00084.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.